www.endosafe.de Gehe zur Webseite
Charles River Laboratories | Every Step of the Way.
At Charles River, our mission is to provide exactly what researchers need to develop new therapeutics for patients as rapidly as possible.
| Sprache/Land: |  EN |
Wichtigste Keywords
Charles River Charles River Laboratories to provide Step of develop Research Therapeutic Therapeutics Basic Research Therapeutic Areas challenges of administration Integrated Genetically Engineered Model Services ocular cell-based therapies Integrated Drug Discovery Assay Development Screening Avian Vaccine Services Chemicals Agro Vet Synthetic Medicinal Chemistry Clinical Laboratory Support Operations Staffing Support Central Nervous System News Events Education Training Investor Relations Musculoskeletal Disease Metabolic Disease Strain Typing Specialty Toxicology Contact Us Endotoxin Detection Biologics Testing regulatory documents Safety Assessment Clinical Support manufacturing support Privacy Policy Clinical Pathology nonclinical development Toxicology Studies Health Monitoring Products Services Health Reports Vivo Pharmacology Animal Models Careers Facility Find preclinical Library
DNS-Daten
| Host | Klasse | Typ | Ziel |
|---|---|---|---|
| endosafe.de | IN | NS | docks09.rzone.de |
| endosafe.de | IN | NS | shades04.rzone.de |
| endosafe.de | IN | AAAA | |
| endosafe.de | IN | SOA | docks09.rzone.de |
| endosafe.de | IN | MX | smtp.rzone.de |
| endosafe.de | IN | A | 81.169.145.167 |
Server-Ping
PING endosafe.de (81.169.145.167) 56(84) bytes of data. 64 bytes from wa7.rzone.de (81.169.145.167): icmp_req=1 ttl=248 time=8.00 ms 64 bytes from wa7.rzone.de (81.169.145.167): icmp_req=2 ttl=248 time=8.28 ms 64 bytes from wa7.rzone.de (81.169.145.167): icmp_req=3 ttl=248 time=7.17 ms 64 bytes from wa7.rzone.de (81.169.145.167): icmp_req=4 ttl=248 time=7.18 ms --- endosafe.de ping statistics --- 4 packets transmitted, 4 received, 0% packet loss, time 602ms rtt min/avg/max/mdev = 7.179/7.662/8.284/0.491 ms
HTTP-Header
| HTTP-Tag | Wert |
|---|---|
| http_version | HTTP/1.1 |
| statuscode | 200 |
| date | Mon, 25 Aug 2014 04:19:24 GMT |
| server | Microsoft-IIS/7.5 |
| content-type | text/html; charset=utf-8 |
| cache-control | private, no-store, must-revalidate |
| x-aspnet-version | 4.0.30319 |
| x-frame-options | SAMEORIGIN |
| x-powered-by | ASP.NET |
| content-encoding | gzip |
| vary | Accept-Encoding |
| set-cookie | CMSCurrentTheme=CharlesRiverLabs; expires=Tue, 26-Aug-2014 04:19:24 GMT; path=/; HttpOnly |
| transfer-encoding | chunked |
Meta Tags
| Meta-Tag | Wert |
|---|---|
| description | At Charles River, our mission is to provide exactly what researchers need to develop new therapeutic... |
| keywords | drug discovery, drug development |
| viewport | width=device-width, initial-scale=1 |
| content-type | text/html; charset=UTF-8 |
| pragma | no-cache |
| content-style-type | text/css |
| content-script-type | text/javascript |
Interne Links
Externe Links
| Anchor | URL |
|---|---|
| Severe Asthma: A TranslationalIn Vivo Model | http://www.cvent.com/events/charles-river-webinar-severe-asthma-a-translational-in-vivo-mo... |
| Ocular Cell-Based Therapies: Overcoming Challenges of Administration and Interpretation in Animal Models | http://www.cvent.com/events/charles-river-webinar-ocular-cell-based-therapies-overcoming-c... |
| Biotechnology-Derived Therapeutics: Perspectives on Nonclinical Development | http://www.cvent.com/events/biotechnology-derived-therapeutics-perspectives-on-nonclinical... |
| http://twitter.com/?_escaped_fragment_=/criverlabs/ | |
| http://www.facebook.com/charlesriverlabs/ | |
| http://www.linkedin.com/company/8306?trk=tyah/ | |
| YouTube | http://youtube.com/user/CharlesRiverLabs/ |
